quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:04:13·45d
SECFiling
Voyager Therapeutics Inc. logo

Voyager Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

VYGR· Voyager Therapeutics Inc.
Health Care
Original source

Companies

  • VYGR
    Voyager Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jan 10UpdateCantor Fitzgerald-
  • Dec 2UpdateCitigroup$12.00
  • Nov 29UpdateWedbush$11.00
  • Oct 16UpdateLeerink Partners$15.00
  • Mar 26UpdateGuggenheim$22.00
  • Mar 19UpdateH.C. Wainwright$30.00

Related

  • SEC2d
    Voyager Therapeutics Inc. filed SEC Form 8-K: Leadership Update
  • SEC13d
    SEC Form PRE 14A filed by Voyager Therapeutics Inc.
  • INSIDER20d
    SEC Form 4 filed by Sandrock Alfred
  • INSIDER20d
    SEC Form 4 filed by Shiferman Gregory L.
  • SEC21d
    SEC Form 144 filed by Voyager Therapeutics Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Voyager Therapeutics Inc.
  • SEC45d
    SEC Form 10-K filed by Voyager Therapeutics Inc.
  • PR45d
    Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022